Nektar Therapeutics(CH:NKTR)
CH:NKTR
Nektar Therapeutics earnings date
Nektar Therapeutics (NKTR) Q2 2026 Earnings Report
1 Followers
CH:NKTR Q2 2026 EPS Results
- Actual EPS
- -CHF 1.03
- Consensus EPS
- -CHF 1.65
- Beat/Miss
- Beat by +CHF 0.62
- One Year Ago EPS
- -CHF 2.46
CH:NKTR Q2 2026 Revenue Results
- Actual Revenue
- CHF 8.46M
- Expected Revenue
- CHF 8.71M
- Beat/Miss
- Missed by -CHF 245.58K
- YoY Revenue Growth
- -9.34%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- After Close
- Conference Call
- Thursday, August 13, 2026
CH:NKTR Upcoming Earnings
Nektar Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:NKTR Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:NKTR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -2.08- | -1.49 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -1.73-1.36 | -1.56 | 12.83% (+0.20) | |
| Aug 13, 2026 | 2026 (Q2) | -1.65-1.03 | -2.46 | 58.31% (+1.44) | |
| May 07, 2026 | 2026 (Q1) | -1.32-1.52 | -3.01 | 49.44% (+1.49) | |
| Mar 12, 2026 | 2025 (Q4) | -2.07-1.49 | 0.38 | -495.56% (-1.86) | |
| Nov 06, 2025 | 2025 (Q3) | -2.24-1.56 | -2.26 | 30.74% (+0.69) | |
| Aug 07, 2025 | 2025 (Q2) | -2.53-2.46 | -3.13 | 21.33% (+0.67) | |
| May 08, 2025 | 2025 (Q1) | -2.14-3.01 | -2.38 | -26.32% (-0.63) | |
| Mar 12, 2025 | 2024 (Q4) | -1.700.38 | -2.76 | 113.64% (+3.13) | |
| Nov 07, 2024 | 2024 (Q3) | -2.49-2.26 | -3.01 | 25.00% (+0.75) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

